AU2377392A - A method for the identification of protease inhibitors - Google Patents

A method for the identification of protease inhibitors

Info

Publication number
AU2377392A
AU2377392A AU23773/92A AU2377392A AU2377392A AU 2377392 A AU2377392 A AU 2377392A AU 23773/92 A AU23773/92 A AU 23773/92A AU 2377392 A AU2377392 A AU 2377392A AU 2377392 A AU2377392 A AU 2377392A
Authority
AU
Australia
Prior art keywords
identification
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23773/92A
Inventor
Robert Balint
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2377392A publication Critical patent/AU2377392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/34011—Potyviridae
    • C12N2770/34022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU23773/92A 1991-07-09 1992-07-09 A method for the identification of protease inhibitors Abandoned AU2377392A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72783791A 1991-07-09 1991-07-09
US727837 1996-09-27

Publications (1)

Publication Number Publication Date
AU2377392A true AU2377392A (en) 1993-02-11

Family

ID=24924278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23773/92A Abandoned AU2377392A (en) 1991-07-09 1992-07-09 A method for the identification of protease inhibitors

Country Status (2)

Country Link
AU (1) AU2377392A (en)
WO (1) WO1993001305A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
US6117639A (en) * 1998-08-31 2000-09-12 Vertex Pharmaceuticals Incorporated Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
WO2002018588A1 (en) * 2000-08-29 2002-03-07 Novozymes A/S Method for screening highly active proteases and inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059482T3 (en) * 1987-12-23 1994-11-16 Boehringer Ingelheim Int EXPRESSION OF HRV2 PROTEASE P2A CODED BY VIRUSES.

Also Published As

Publication number Publication date
WO1993001305A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
HU9601508D0 (en) Dp-iv-serine protease inhibitors
EP0580402A3 (en) Aminediol protease inhibitors
AU7729694A (en) Method for inhibiting metalloproteinase expression
PL326508A1 (en) Protease inhibitors
KR100190517B1 (en) Hiv protease inhibitors
AU632836B2 (en) Novel peptidase inhibitors
ZA929869B (en) Hiv protease inhibitors
AU2191492A (en) Novel phospholipase a2 inhibitors
AU3585293A (en) Beta-amyloid peptide production inhibitors and methods for their identification
IL102534A0 (en) Retroviral protease inhibitors
AU7875494A (en) Method for inhibiting angiogenesis
AU1960488A (en) Cysteine proteinase inhibitor
AU3392893A (en) Methods for preventing the expression of a protease
AU5069993A (en) Retroviral protease inhibitors
AU7963394A (en) Mercaptosulfide metalloproteinase inhibitors
AU5913190A (en) Peptidyl aminodiol renin inhibitors
AU656027B2 (en) Saccharin derivative proteolytic enzime inhibitors
ZA945234B (en) Process for making HIV protease inhibitors
AU6828894A (en) Hiv protease inhibitors
AU2377392A (en) A method for the identification of protease inhibitors
AU3735793A (en) Retroviral protease inhibitors
AU6193490A (en) Peptidyl difluorodiol renin inhibitors
PL292500A1 (en) Method of obtaining a protease inhibitor
EP0575500A4 (en) Hiv protease inhibitors
AU6450590A (en) Renin inhibitors